MedlinePlus Health Prescriptions: Developing a Pragmatic Approach for Clinic Use
This study has been completed.
Sponsor:
University of Missouri-Columbia
Collaborator:
Information provided by:
University of Missouri-Columbia
ClinicalTrials.gov Identifier:
NCT01050465
First received: January 13, 2010
Last updated: March 1, 2011
Last verified: March 2011
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The specific aim of this proposed pilot study is to compare two standardized processes (paper and electronic) to deliver a customized MedlinePlus health information prescription.
Primary Hypothesis. Individuals in the paper prescription group will be just as likely to seek information using MedlinePlus compared with individuals in the group who receive the same customized information through an email prescription.
Secondary Hypothesis. Individuals in the paper prescription group will be just as likely to have successful behavioral outcome measures as those in the group who receive the same customized information through an email prescription.
| Condition | Intervention |
|---|---|
|
Acne Vulgaris Allergic Rhinitis (Disorder) Anxiety Asthma Back Pain Prostatic Hyperplasia Bursitis Chronic Obstructive Pulmonary Disease Cough Coronary Artery Disease Depression Diabetes Mellitus Diarrhea Gastroesophageal Reflux Fibromyalgia Headache HIV Infections Hypothyroidism Hyperlipidemia Hypertension Influenza Sleep Initiation and Maintenance Disorders Irritable Bowel Syndrome Knee Pain Migraine Disorders Obesity Obstructive Sleep Apnea Osteoarthritis Senile Osteoporosis Colonoscopy Mammography Shoulder Pain Sinusitis Smoking Cessation Tobacco Use Cessation Menopause Urinary Incontinence Urinary Tract Infection Vaccination Vaginitis Vertigo |
Other: health information prescription |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Intervention Model: Parallel Assignment Masking: Open Label |
Resource links provided by NLM:
MedlinePlus related topics:
Anxiety
Dizziness and Vertigo
HIV/AIDS
Headache
High Blood Pressure
Urinary Tract Infections
U.S. FDA Resources
Further study details as provided by University of Missouri-Columbia:
Primary Outcome Measures:
- seeking information using MedlinePlus [ Time Frame: clicks will be tracked on the website when they occur ] [ Designated as safety issue: No ]
| Estimated Enrollment: | 728 |
| Study Start Date: | May 2009 |
| Study Completion Date: | December 2010 |
| Primary Completion Date: | October 2010 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
Active Comparator: email
Patients randomized to this arm will receive an email health information prescription.
|
Other: health information prescription
Patients randomized to the email arm will receive a health information prescription via email on a health care topic following their clinic visit. Patients randomized to the paper arm will receive a health information prescription on paper on a health care topic following their clinic visit.
|
|
Active Comparator: paper
Patients randomized to this arm will receive a paper health information prescription.
|
Other: health information prescription
Patients randomized to the email arm will receive a health information prescription via email on a health care topic following their clinic visit. Patients randomized to the paper arm will receive a health information prescription on paper on a health care topic following their clinic visit.
|
Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | Yes |
Criteria
Inclusion Criteria:
- To be included in the study population, patients must be seen by their physician for one of the 40 target health conditions.
Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study.
To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below.
For general information, see Learn About Clinical Studies.
Please refer to this study by its ClinicalTrials.gov identifier: NCT01050465
Please refer to this study by its ClinicalTrials.gov identifier: NCT01050465
Sponsors and Collaborators
University of Missouri-Columbia
Investigators
| Principal Investigator: | Robert Hodge, MD | University of Missouri-Columbia |
More Information
No publications provided by University of Missouri-Columbia
Additional publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
| Responsible Party: | Robert Hodge, University of Missouri |
| ClinicalTrials.gov Identifier: | NCT01050465 History of Changes |
| Other Study ID Numbers: | HHSN276200800445P |
| Study First Received: | January 13, 2010 |
| Last Updated: | March 1, 2011 |
| Health Authority: | United States: Institutional Review Board |
Keywords provided by University of Missouri-Columbia:
|
HIV |
Additional relevant MeSH terms:
|
Coronary Artery Disease Coronary Disease Diabetes Mellitus Disease Gastroesophageal Reflux Irritable Bowel Syndrome Lung Diseases, Obstructive Migraine Disorders Myocardial Ischemia Prostatic Hyperplasia Pulmonary Disease, Chronic Obstructive Rhinitis Sleep Apnea, Obstructive Urinary Incontinence Urinary Tract Infections |
Apnea Arterial Occlusive Diseases Arteriosclerosis Brain Diseases Cardiovascular Diseases Central Nervous System Diseases Colonic Diseases Colonic Diseases, Functional Deglutition Disorders Digestive System Diseases Dyssomnias Endocrine System Diseases Esophageal Diseases Esophageal Motility Disorders Gastrointestinal Diseases |
ClinicalTrials.gov processed this record on March 01, 2015